Navigation Links
Migraine Treatment Centers of America Welcomes Chronic Migraine Specialist in Phoenix, AZ
Date:3/2/2013

Phoenix, AZ (PRWEB) March 02, 2013

Migraine Treatment Centers of America (“Migraine Centers”) is pleased to welcome Abram Burgher, M.D. in the Phoenix, Arizona area. This new and exciting partnership will offer the Omega migraine procedure at Freedom Pain Hospital, the nation's first pain hospital.

Utilizing technology that is similar to a pacemaker, the Omega migraine procedure is used to treat chronic migraine pain through the implantation of a small device. The device confuses the nerves associated with chronic migraine pain, which prevents the pain signal from reaching the brain.

The Omega procedure is covered by most insurance providers for qualified patients, has seen a 90% success rate in targeted migraine conditions, and is designed to provide long-lasting pain relief. Prior to permanent implantation, each patient will undergo a trial, in which they will be able to determine whether the device offers sufficient pain relief and improved function.

The Omega procedure is offering hope, pain relief, and improved function to those who suffer from this debilitating, painful condition. Cynthia B., a migraine sufferer who has undergone the Omega procedure, says, “My professional and personal life has improved dramatically. I have not had to miss one day of work because of migraines. I’ve also been able to get off of all preventative medications.”

Dr. Burgher is a Phoenix-based, double board-certified pain management expert who completed his internship, residency, and fellowship in Pain Management at the world-renowned Mayo Clinic in Rochester, MN.

Dr. Burgher treats patients with chronic pain from conditions including migraines, chronic headaches and trigeminal neuralgia, with the help of the surgical facilities at Freedom Pain Hospital in Scottsdale, Arizona. This acute care and outpatient surgical facility is dedicated to a multi-disciplinary, complementary approach in the evaluation, diagnosis, and treatment of chronic pain.

In addition to his clinical practice, Dr. Burgher is dedicated to research, and works diligently toward furthering to technology development in the area of pain management. He is currently involved in clinical research in patient care and safety for individuals suffering with chronic pain. He is a clinical investigator and the Director of Investigator Relations at the HOPE Research Institute, and Vice President for Clinical Innovations at Pain Care Solutions. Dr. Burgher's main area of interest is on the applications for implanted pain therapy devices that can help manage chronic nerve pain.

Dr. Burgher is the lead author of various publications in peer-reviewed medical journals, as well as co-lead researcher in a human clinical trial supported by the National Institutes of Health.

“Dr. Abram Burgher’s pain management expertise and interest in advanced solutions for treatment make him an excellent partner for Migraine Treatment Centers of America in Phoenix,” said Alex Noffsinger, president of Migraine Centers.

About Migraine Treatment Centers of America

Migraine Treatment Centers of America (“Migraine Centers”) is committed to helping chronic migraine sufferers by providing access to educational tools, a network of leading physicians board-certified in interventional pain management, and evidence-based medical procedures to treat chronic migraine pain.

Migraine Centers is recognized for its Omega™ migraine procedure, a drug-free and long-lasting solution for chronic migraine pain. Its approach, based on a technique used for over 40 years, has been featured in numerous medical publications.

To learn more about Migraine Treatment Centers of America, visit migrainecenters.com.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10488742.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Ice Cream Headaches Might Offer Clues to Migraines
2. Botox Offers Little Relief for Migraine, Study Finds
3. Migraines More Likely for People With Celiac Disease, Study Says
4. Two-Drug Combo Helps Teens With Migraines
5. Few Migraine Sufferers Referred for Behavioral Treatments
6. Red Wine, Weather May Trigger Migraines
7. Relief for Migraine Sufferers as The Life House Offers New Findings, Free Consults
8. Published clinical trial demonstrates efficacy of Sea-Band for migraine-related nausea
9. Good news: Migraines hurt your head but not your brain
10. Migraines Not Linked to Decline in Thinking Skills
11. Behavior issues are a bigger headache for children with migraines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... Dr. Andrew Lian-Jie ... and fellowship trained Mohs and cosmetic surgeon. After extensive dermatology research training at ... his internship in internal medicine at the Emory University and dermatology training at ...
(Date:1/19/2017)... NY (PRWEB) , ... January 19, 2017 , ... ... of Clinical Conductor CTMS, which provides a modern CTMS workflow designed to seamlessly ... management information has been condensed to a single page, maximizing usability and improving ...
(Date:1/19/2017)... ... January 19, 2017 , ... Students interested in video can get a ... The winner will earn a $1,000 scholarship and have his or her video posted ... the deadline is May 31, with the winner announced on June 9. , The ...
(Date:1/19/2017)... ... 19, 2017 , ... Workrite Ergonomics announced this week the ... privacy panel system was designed to deliver the ideal blend of acoustic and ... provide the visual privacy required to maintain concentration levels and increase productivity. The ...
(Date:1/19/2017)... ... January 19, 2017 , ... Allegheny Health Network (AHN) ... who seek access to the Network’s programs and services in the greater Pittsburgh region. ... care appointments will be offered one for that same afternoon. , AHN ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 2017  Sensus Healthcare, Inc. (NASDAQ: ... the treatment of non-melanoma skin cancers and other ... therapy, today announced that it will report its ... on Thursday, February 2, 2017 after the market close. ... call with the investment community on Thursday, February 2, ...
(Date:1/19/2017)... 19, 2017   Science Exchange , the leading ... that the first five replication studies from the ... published in eLife today. Despite intense scrutiny around ... practical evaluation of reproducibility rates that may identify ... other assessments of reproducibility, the results of this ...
(Date:1/19/2017)... 2017 While various reports ... reducing the FDA,s regulatory strictness as a way ... drug industry, many of the leading biotech and ... and development of advanced drug treatments and therapies.  ... developments include:  Moleculin Biotech, Inc., (NASDAQ: ...
Breaking Medicine Technology: